The Journal of Allergy and Clinical Immunology. in Practice
Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”
DOI 10.1016/j.jaip.2020.11.056 , Volume: 9 , Issue: 2 , Pages: 1039-1040
Article Type: letter, Article History

Table of Contents



Bansal, Hare, Bajowala, Abramson, Chervinskiy, Corriel, Hauswirth, Kakumanu, Mehta, Rashid, Rupp, Shih, and Mosnaim: Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”

To the Editor:

Waqar and Agarwal1 make significant points regarding the rapid adoption of technology, specifically telemedicine, into fellowship programs. As all of the authors in the American Academy of Allergy, Asthma & Immunology telemedicine work group will attest to, many factors need to be taken into account before adopting a functional telemedicine platform in the clinic. Keeping up with current regulations to maintain compliance in light of the changes during the COVID-19 pandemic and beyond also requires considerable effort.2 What is uniquely addressed in this letter are the practical issues that allergists and immunologists face with telemedicine. Although spirometry is limited at this time, technologies are being created and implemented to accomplish home forced expiratory volume in 1 second measurement.3 Assessing and teaching the inhaler and emergency epinephrine device technique can be performed remotely and re-evaluated at follow-up visits via telemedicine. Telemedicine has also been valuable to evaluate and monitor our most at-risk patients, such as those with immunodeficiency, as they may be fearful of returning to the clinic for routine in-person evaluations. Time will reveal more data in our field as we are able to obtain cost-benefit analysis for allergy and immunology telemedicine encounters. By providing innovative, valuable, and cost-effective care while educating our fellows and continuing to rapidly adapt in times of need, we will persist in pushing open the door of modern medical technology in health care.


    Waqar O., Agarwal S.. The forced renaissance of telemedicine during COVID-19: a fellow-in-training’s perspective. J Allergy Clin Immunol Pract 9: 2021. 1039

    Hare N., Bansal P., Bajowala S.S., Abramson S.L., Chevinskiy S., Corriel R.. Work Group Report: COVID-19: unmasking telemedicine. J Allergy Clin Immunol Pract 8: 2020. 2461-2473

    Kupczyk M., Hofman A., Koltowski L., Kuna P., Lukaszyk M., Buczylko K.. Home self-monitoring in patients with asthma using a mobile spirometry system. doi: 10.1080/02770903.2019.1709864


No funding was received for this work.
Conflicts of interest: P. Bansal has served on the advisory boards for Genentech, Regeneron, Kaleo, AstraZeneca, ALK, Shire, Takeda, Pharming, CSL Behring, and Teva; is a speaker for AstraZeneca, Regeneron, ALK, Takeda, Shire, CSL Behring, Takeda, and Pharming; and has served as an independent consultant for ALK, AstraZeneca, and Exhale. G. S. Mosnaim has received research grant support from 10.13039/100004325AstraZeneca, 10.13039/100004330GlaxoSmithKline, and Propeller Health; owned stock in Electrocore; and has served as a consultant and/or member of a scientific advisory board for GlaxoSmithKline, Sanofi-Regeneron, Teva, Novartis, Astra Zeneca, Boehinger Ingelheim, and Propeller Health. The rest of the authors declare that they have no relevant conflicts of interest.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”&author=Priya Bansal,Nathan Hare,Sakina S. Bajowala,Stuart L. Abramson,Sheva Chervinskiy,Robert Corriel,David W. Hauswirth,Sujani Kakumanu,Reena Mehta,Quratulain Rashid,Michael R. Rupp,Jennifer Shih,Giselle S. Mosnaim,&keyword=&subject=Correspondence and Reply,